CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Trial details
- Registry ID
- NCT04495153
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLCNCT04495153 | CADL | Phase 2 | Active not recruiting | 2024-12-31Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |